Vivin Drugs & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 16.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 11.28 Cr
as on 24-10-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 267.67 Cr
as on 24-10-2024
- Satisfied Charges ₹ 50.95 Cr
as on 24-10-2024
- Revenue -25.48%
(FY 2023)
- Profit -41.09%
(FY 2023)
- Ebitda 4.44%
(FY 2023)
- Net Worth 2.88%
(FY 2023)
- Total Assets 7.67%
(FY 2023)
About Vivin Drugs & Pharmaceuticals
The Corporate was formerly known as Vivin Drugs & Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 16.00 Cr and a paid-up capital of Rs 11.28 Cr.
The company currently has active open charges totaling ₹267.67 Cr. The company has closed loans amounting to ₹50.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vivin Drugs & Pharmaceuticals Private Limited India is Sweety Agarwal as COMPANY SECRETARY. Parvathaiah Botta, Sumanth Botta, and Botta Anuradha serve as directors at the Company.
- CIN/LLPIN
U24232TG2011PLC075704
- Company No.
075704
- Incorporation Date
28 Jul 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vivin Drugs & Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumanth Botta  | Managing Director | 28-Jul-2011 | Current |
| Botta Anuradha | Managing Director | 28-Jul-2011 | Current |
| Sweety Agarwal | Company Secretary | 01-Jun-2023 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parvathaiah Botta | Whole-Time Director | 28-Jul-2011 | Current |
Financial Performance of Vivin Drugs & Pharmaceuticals.
Vivin Drugs & Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.48% decrease. The company also saw a substantial fall in profitability, with a 41.09% decrease in profit. The company's net worth moved up by a moderate rise of 2.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivin Drugs & Pharmaceuticals?
In 2023, Vivin Drugs & Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vivin Life Sciences LimitedActive 14 years 8 monthsParvathaiah Botta, Sumanth Botta and 1 more are mutual person
Vivin Laboratories Private LimitedActive 20 years 8 monthsParvathaiah Botta, Sumanth Botta and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Mar 2023 | ₹20.00 Cr | Open |
Hdfc Bank Limited Creation Date: 09 Dec 2022 | ₹1.33 Cr | Open |
Hdfc Bank Limited Creation Date: 25 Nov 2022 | ₹2.75 M | Open |
How Many Employees Work at Vivin Drugs & Pharmaceuticals?
Vivin Drugs & Pharmaceuticals has a workforce of 195 employees as of Sep 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivin Drugs & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivin Drugs & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
